Aquestive Therapeutics, Inc. Common Stock AQST
$4.66
+3.67%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | PRIMARY DOCUMENT | 2026-08-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-08-17 | View → |
| 10-Q | 10-Q | 2026-08-11 | View → |
| 8-K | 8-K | 2026-08-11 | View → |
| 8-K | 8-K | 2026-08-10 | View → |
| 4 | PRIMARY DOCUMENT | 2026-07-17 | View → |
| S-3 | S-3 | 2026-06-26 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-24 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-16 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-12 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-12 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-12 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-12 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-12 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-12 | View → |
| 8-K | 8-K | 2026-06-10 | View → |
| 4 | PRIMARY DOCUMENT | 2026-06-09 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-19 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-18 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-18 | View → |
| 10-Q | 10-Q | 2026-05-13 | View → |
| 8-K | 8-K | 2026-05-13 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-11 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-07 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-07 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-07 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-07 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-07 | View → |
| DEF 14A | DEF 14A | 2026-04-24 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-13 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-13 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-13 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-13 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-13 | View → |
| 4 | PRIMARY DOCUMENT | 2026-04-13 | View → |
| 8-K | 8-K | 2026-03-30 | View → |
| 8-K | 8-K | 2026-03-20 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-11 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-11 | View → |
| 4 | PRIMARY DOCUMENT | 2026-03-11 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $4.66
- Market Cap
- $584.88 million
- 52-Week Range
- $2.93 – $7.55
- Average Volume
- 3.06 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.